These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Electron microscopic, immunofluorescent and virological studies on a rhabdomyosarcoma in epidermodysplasia verruciformis. Yabe Y; Koyama H Acta Med Okayama (1952); 1971; 25(6):643-8. PubMed ID: 4264056 [No Abstract] [Full Text] [Related]
28. Studies on the nature of epidermodysplasia verruciformis of Lewandowsky-Lutz as a precancerous condition. Jablońska S; Jakubowicz K; Langner A; Biczysko W; Dabrowski J Pol Med J; 1970; 9(6):1581-8. PubMed ID: 5505070 [No Abstract] [Full Text] [Related]
29. [Human warts by Papovavirus. Clinical, histological and ultrastructural correation]. Rueda Plata LA Med Cutan Ibero Lat Am; 1976; 4(2):. PubMed ID: 988449 [TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of the expression of cytokeratins (1, 10, 14, 16, 4), involucrin, filaggrin and e-cadherin in plane warts and epidermodysplasia verruciformis plane wart-type lesions. Barcelos AC; Sotto MN J Cutan Pathol; 2009 Jun; 36(6):647-54. PubMed ID: 19515043 [TBL] [Abstract][Full Text] [Related]
31. Familial epidermodysplasia verruciformis of Lewandowsky and Lutz. Rajagopalan K; Bahru J; Loo DS; Tay CH; Chin KN; Tan KK Arch Dermatol; 1972 Jan; 105(1):73-8. PubMed ID: 5009624 [No Abstract] [Full Text] [Related]
32. Characterization of a human papillomavirus from epidermodysplasia verruciformis lesions of a patient from Upper-volta. Pfister H; Nürnberger F; Gissmann L; zur Hausen H Int J Cancer; 1981 May; 27(5):645-50. PubMed ID: 6270020 [TBL] [Abstract][Full Text] [Related]
33. A novel human papillomavirus identified in epidermodysplasia verruciformis. Harris AJ; Purdie K; Leigh IM; Proby C; Burge S Br J Dermatol; 1997 Apr; 136(4):587-91. PubMed ID: 9155964 [TBL] [Abstract][Full Text] [Related]
34. [Epidermodysplasia verruciformis: ultrastructural and autoradiographic study]. Grupper C; Pruniéras M; Delescluse C; Arouète J; Garelly E Ann Dermatol Syphiligr (Paris); 1971; 98(1):33-47. PubMed ID: 5580272 [No Abstract] [Full Text] [Related]
36. [Lewandowski-Lutz verruciformi epidermodysplasia with cellular atypic signs in all its lesions]. Grinspan D; Abulafia J; Sanchez Caballero J Med Cutan Ibero Lat Am; 1974; (1):5-13. PubMed ID: 4478209 [No Abstract] [Full Text] [Related]
37. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Feltkamp MC; Broer R; di Summa FM; Struijk L; van der Meijden E; Verlaan BP; Westendorp RG; ter Schegget J; Spaan WJ; Bouwes Bavinck JN Cancer Res; 2003 May; 63(10):2695-700. PubMed ID: 12750299 [TBL] [Abstract][Full Text] [Related]
38. Skin autografts in epidermodysplasia verruciformis: human papillomavirus-associated cutaneous changes need over 20 years for malignant conversion. Majewski S; Jablonska S Cancer Res; 1997 Oct; 57(19):4214-6. PubMed ID: 9331078 [TBL] [Abstract][Full Text] [Related]